Secretary Robert F. Kennedy Jr. remains firmly in place as HHS Secretary over a year after Senate confirmation in February 2025, driving 76.5% trader consensus against his departure by December 31, 2026, amid persistent but unrealized pressure for resignation. Recent February 2026 leadership shakeups saw two top aides exit HHS in a White House-backed restructuring ahead of midterm elections, while April reports highlight his team being sidelined, a pivot away from vaccine rhetoric per internal memos, and lawsuits challenging agency overhauls—including a federal judge's block on vaccine recommendation cuts. Despite employee petitions in September 2025 and Democratic calls to fire him, no official withdrawal or dismissal has materialized, bolstering bets on his tenure through year-end amid ongoing operational turmoil.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Secretary Robert F. Kennedy Jr. remains firmly in place as HHS Secretary over a year after Senate confirmation in February 2025, driving 76.5% trader consensus against his departure by December 31, 2026, amid persistent but unrealized pressure for resignation. Recent February 2026 leadership shakeups saw two top aides exit HHS in a White House-backed restructuring ahead of midterm elections, while April reports highlight his team being sidelined, a pivot away from vaccine rhetoric per internal memos, and lawsuits challenging agency overhauls—including a federal judge's block on vaccine recommendation cuts. Despite employee petitions in September 2025 and Democratic calls to fire him, no official withdrawal or dismissal has materialized, bolstering bets on his tenure through year-end amid ongoing operational turmoil.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions